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1. Introduction 
Liver niicrosomal preparations from rats were re- 
cently shown to convert various neutral 16-dehydro- 
Cl9 steroids into 16, 17-dihydroxylated metabolites 
[I] This reaction probably proceeds via the inter- 
mediary formation of a 16, 17-epoxide. The present 
study was carried out in order to determine whether 
cytochrome P-450 is involved in the microsomal oxy- 
genation of the Al6 double bond. 
2. Materials and methods 
4, 16-Androstadien-3-one was supplied by Dr. 
B.W.L. Brooksbank (West Park Hospital, Surrey, 
England) and 16~~. 17&-epoxy-Sa-androstan-3c+ol was 
donated by Dr. C.L. Hewitt (Organon Laboratories, 
Newhouse, Scotland). 4, 16- [ 7a-3 H] -Acdrostadien-3- 
one (specific activity 13.5 Ci/mole) was given by Dr. 
D.B. Cower (Guy’s Hospital Medical School, London, 
S.E. 1, England). 
Liver microsomes were prepared from male rats of 
the Sprague-Dawley strain as described previously [ 1) . 
5OG 100 /_q unlabelled 4, 16-androstadien-3-one and 
50,000 cpm of 4, 16-[ 7cu-” H] -androstadien-3-one were 
dissolved in 50 ~1 of acetone and added to varying 
amounts of microsomal suspension together with 0.03 
pmoles of MnCl, , 3 pmoles NADP, 12.5 pmoles of 
isocitrate and 10 ~1 of isocitric dehydrogenase solution 
[2] in a total volume of 4 ml of Bucher medium [3] 
and incubated for 10 min at 37” (standard conditions). 
The incubations were terminated by the addition of 
North-Holland Publishing Company - Amsterdam 
20 vol of clilorof~oriii~methanol. 2: 1 (v/v). The preci- 
pitate was filtered off and 0.9 vol of a O.O’%’ (w/v) 
aqueous sodium chloride solution were added. The 
chloroform phase was reduced under vacuum and the 
residue was chromatographed on a IO g column of 
Sephadex LH-20 prepared in and elu ted with chloro- 
form~heptane--ethanol. S:5: I (by vol). Two fraction! 
were collected: fraction A (O-50 ml of effluent) and 
fraction B ( 100 ml of methanol). One tenth of each 
fraction was measured for radioactivity in a Packard 
liquid scintillation counter (Model 4321) using Insta- 
gel@. Aliquots of fractions A and B were also taken 
for preparation of trimethylsilyl (silyl) ethers which 
were then analyscd by gas chromatography~Inass 
spectrometry. Spectra were recorded on magnetic tape 
using the incremental mode of operation and were the 
treated in an IBM 1800 computer [4] 
In a separate experiment four rats were given intra- 
peritoneal injections of phenobarbital (80 mg/kg) for 
three days. Four control rats were injected with saline 
The rats were killed and liver microsomal fractions 
were prepared as described above. Microsomal fraction 
from two rats in the same experimental group were 
pooled prior to incubation. 100 pg of4, 16-androsta- 
dien-3-one was incubated for IO min with 0. 0.2, 0.5 
and I .O ml of microsomal fraction. The incubations 
were stopped and the extracts were further processed 
as described above. 
Liver niicrosomes for spectral measurements were 
isolated according to Ernster et al. [ 51 The micro- 
soma pellets were suspended in 0. I5 M Tris-Cl buffer 
(pH 8.0) and recentrifuged at 105,OOOg for 40 min. 
The pellets were resuspended in a 0.25 M sucrose so- 
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Fig 1. Effect of enzyme concentration, time and substrate concentration on hepatic microsomal formation of 16p, 17@+di- 
hydroxylated C,g steroids from 4, 16-[7cu-3H]androstadien-3-one. A) Effect of enzyme concentration; B) effect of time; C) effect 
of substrate concentration. Standard conditions were used (cf. Materials and methods). 
lution. Protein was measured according to Lowry et 
al. [6] and cytochrome P-450 according to Schenkman 
et al. [7]. 
The spectral changes produced by the addition of 
the various compounds to the microsomal suspensions 
were recorded with an Aminco-Chance dual-wavelength 
split-beam scanning spectrophotometer. Each cuvette 
contained microsomal suspension. 50 mM Tris-Cl (pH 
7.5) and 15 mM KC1 in a final volume of 3 ml. The 
substance under study was added to the sample cuvette 
and an equivalent amount of the solvent was added to 
the reference cuvette. 
In some experiments we studied the influence of 
carbon monoxide on the formation of 16, 17-dihydrox- 
ylated metabolites from 4, 16-androstadien-3-one. 
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During these experiments the incubation medium was 
bubbled with a gas mixture containing 4% 02, 4W 
CO and 56% N;, . Incubations performed with micro- 
somes bubbled with 4% O2 and 96% N, served as con- 
trols. 
3. Results 
Gas chromatography-mass spectrometry analysis 
of fractions A and B after chromatography of extracts 
obtained from incubation of 4, I6-androstadien-3-one 
with liver microsomes from male rats showed that 
fraction A contained the incubated substrate whereas 
fraction B contained a mixture of the following ring 
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D-saturated 16, 17-dihydroxylated steroids (for identi- 
fication procedure, see [ 11): 3a, 17&dihydroxy-5a- 
androstan-16-one (minor metabolite), 160, 17o-di- 
hydroxy-5a-androstan-3-one, 1613, 17a-dihydroxy-4- 
androstan-3-one (major metabolite), 5a-androstane-3a, 
168, 17~trio1 and So!-androstane-3f3, 160, 17a-triol. 
Fig. 1 shows the effect of enzyme concentration, 
substrate concentration and the on the oxygenation 
of 4, 16-[7~~H]androstadien-3-one to 16, 17-di- 
hydroxylated compounds by microsomal fraction in 
the presence of an NADPH-regenerating system. 
Microsomes from rats pretreated with phenobar- 
bital converted 13.7 nmoles of 4, 16-androstadien-3- 
one/mg protein X 10 min to 16, 17-dihydroxylated 
metabolites. The corresponding figure for control rats 
was 8.1 nmoles/mg protein X IO min. Gas chromato- 
graphy-mass spectrometry analysis of fraction B 
from the Sephadex LH-20 chromatography of the in- 
cubation extract showed the same qualitative and 
quantitative composition of 16, 17-dihydroxylated 
metabohtes after incubation with control (cf. above) 
and phenobarbital microsomes. 
Treatment of microsomes with carbon monoxide 
during the incubation gave 75% inhibition of the con- 
version of 4, 16-androstadien-3-one to 16, 17-di- 
hydroxylated metabolites. 
4, 16-Androstadien-3-one licited the type I spec- 
tral change upon addition to microsomal suspensions. 
The spectral dissociation constants (KS-values) [7] 
ranged from 20 to 54 PM and the maximal optical 
change from 0.004 to 0.009 O.D./mg protein in micro- 
somes from untreated rats. In microsomes from pheno- 
barbital treated rats the latter parameter ranged from 
0.028-0.03 1 O.D./mg protein. 
Since it is plausible that epoxides are intermediates 
during the formation of 1613. 17a-dihydroxylated C ,9 - 
steroids from 16-dehydro-C r9 steroids we performed 
spectral studies on the microsomal interaction on 16a, 
17a-epoxy-Sa-androstan-3Lu-ol ( 16a, 17a-epoxy-4- 
androsten-3-one was not available) and 5a-androst- 16- 
en-3a-01. Both these compounds elicited the type I 
spectral change (fig. 2) the magnitudes (A.O.D. max/ 
mg protein) of which were considerably higher in 
phenobarbital microsomes than in control microsomes. 
The &-values of 160, 17a-epoxy-5a-androstan-3a-ol 
and So-androst- 16-en-3a-ol were similar (% 45 PM). 
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l:ig. 2. Difference spectra elicited by 5&androst-l6-en-3@ol 
(A) and 16~1, 17@cposy-XY-androstan-3~01 (B) to a suspen- 
sion of rat liver microsomes from rats treated with phenobar- 
bital. The concentration of protein was 1.8 mg/ml and the 
concentration of cytochrome P-450 2.5 nmole/me protein. 
The compounds were added to the sample cuvette to give the 
final concentrations depicted in the figure. 
4. Discussion 
4, 16-Androstadien-3-one licits the type 1 spectr-al 
change in rat liver microsomes. Phenobarbital treatmer 
of rats increased and carbon monoxide inhibited the 
microsomal irr vitro formation of 160. 17a-dihydroxy- 
lated metabolites from this substrate. The maximal m; 
nitude of spectral change (A.O.D. max/mg protein) in- 
duced by 4. 16-androstadien-3-one also increased upor 
phenobarbital treatment. These data indicate that the 
liver microsomal cytochrome P-450 is involved in the 
formation of 16, 17-dihydroxylated metabolites from 
16-dehydro-C,, steroids. 
It is plausible that the formation of 160. 17a-di- 
hydroxylated Cl9 steroids occur via an intermediate 
epoxide [ 1] . It is well known that phenobarbital and 
polycyclic hydrocarbon treatment of rats increases 
several cytochrome P-450 dependent oxidations (cf. 
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[Xl. and it has also 
menI stimulates the 
bromobenrenc [ 91 
Fut-thertnore, the 
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been suggested that such tt-eat- 
formation of an epoxide from 
rate of formation of 21 dihydro- 
diol from styrene oxide [IO] is increased by pheno- 
barbital and polycyclic hydrocarbon treatment. The 
conversion of an epoxide to 3 dihydrodiol has been 
proposed to be catalyzed by one or several hy- 
drases [ 111. strictly located in the niicrosotnal t‘t-ac- 
tion [IO] The specific activity of this enc.yme in- 
creases during niatut-ation of rats, which is also true 
for several cy tochrome P-450 dependent reactions 
Since the hydrase seems to follow a similar ma- 
turation and induction pattern and to have the 
same subcellular localiration as liver n~icrosomal 
cytochrome P-450 it is possible that the epoxide 
formation and the consecutive fortuatiotl of dihy- 
drodiols are catalymd by two enLytnes whose ac- 
tivities at-e governed by a COI~II~~I~ regulating sys- 
tem. Another possibility co~tld be that cytochrome 
P-450 is directly involved in the formatioti of dihy- 
dt-odiols from the epoxides. 
In an attempt to test the latter hypothesis we 
performed spectral studies on the interaction of 
1601. 17a-epc’xy-Sot-aiidrostan-3a-ol and Sa-atidt-ost- 
l6-en-3cu-ol with rat liver mitt-oson~es. Both corn-- 
p0t11ids elicited the type I spectral change. the 
magnitude of’ which was larger iii tiiicrosotiies from 
phenobarbital treated trats than in tttict-osotnes from 
control rats. When using tiiicrosonies ft-oni rats 
treated with phenobarbital. the K,s-values for the 
two con~pounds wet-e similar ( s 45 PM) indicating 
that both steroids interact with cytochrorne P-450 
with similar affinities. 
The data suggest that cytochrotne P-450 could 
be involved in the me tabolisrn of epoxides. Since 
both the At” steroid and the corresponding I ha. 
17a-epoxide hind to cy tochrotne P-450 they could 
conceivably cotttpcte with each other’s interaction 
with the cytochrome. If this is true the displace- 
ment of an epoxide from cytochrotne P-450 by its 
parent compound might influence the rate of bio- 
transformation of the epoxide. It cannot be ex- 
cluded that cytochrome P-450 itself catalyzes the 
enzytnatic formation of dihydrodiols from epoxides 
and thus is identical with the so called hydrase. 
The dihydrodiol tnight then possibly be formed 
during the dissociation of the enLyme_ substrate 
complex. 
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